DNA Methylation and Histone Modification in Hypertension

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Epigenetics

Background:

• Systemic hypertension is a prevalent chronic disorder, particularly in elders, often leading to severe complications like heart failure, renal failure, and stroke.
• Despite numerous anti-hypertensive therapies, approximately half of all hypertensive patients remain uncontrolled, highlighting unmet needs in treatment.
• Current research frontiers are exploring epigenomics to understand the molecular underpinnings of hypertension.

Purpose of the Study:

• To review recent advances in understanding epigenetic regulations and mechanisms of hypertension.
• To focus on the roles of DNA methylation and histone modification in the vascular wall of hypertensive individuals.
• To identify potential novel therapeutic targets for hypertension treatment through epigenomic insights.

Main Methods:

• Review of current scientific literature on epigenetics and hypertension.
• Analysis of studies investigating DNA methylation and histone modifications in vascular cells.
• Synthesis of evidence linking epigenetic alterations to hypertension pathophysiology.

Main Results:

• Emerging evidence implicates DNA methylation and histone modifications in regulating gene expression.
• These epigenetic modifications alter the phenotype and function of vascular cells under stress.
• Epigenomic dysregulation is increasingly recognized as a key factor in the development and progression of hypertension.

Conclusions:

• Epigenetic mechanisms, particularly DNA methylation and histone modification, play a significant role in the vascular wall during hypertension.
• A deeper understanding of vascular epigenomics in hypertension may uncover novel molecular targets.
• This knowledge holds promise for the development of innovative drug discoveries for improved hypertension management.